Moderna, Inc.
MRNA
$59.81
$0.641.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.15B | -3.19B | -2.82B | -3.12B | -2.90B |
| Total Depreciation and Amortization | 241.00M | 235.00M | 215.00M | 208.00M | 208.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 464.00M | 496.00M | 501.00M | 519.00M | 498.00M |
| Change in Net Operating Assets | 1.37B | 997.00M | 233.00M | 411.00M | -500.00M |
| Cash from Operations | -1.07B | -1.47B | -1.87B | -1.98B | -2.70B |
| Capital Expenditure | -171.00M | -137.00M | -192.00M | -675.00M | -793.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.08B | 1.28B | 2.14B | 2.13B | 2.27B |
| Cash from Investing | 905.00M | 1.14B | 1.95B | 1.46B | 1.48B |
| Total Debt Issued | 600.00M | 598.00M | 600.00M | -4.00M | -1.00M |
| Total Debt Repaid | -22.00M | -18.00M | -18.00M | -16.00M | -13.00M |
| Issuance of Common Stock | 60.00M | 51.00M | 35.00M | 30.00M | 36.00M |
| Repurchase of Common Stock | -5.00M | -3.00M | -2.00M | -1.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.00M | -22.00M | -22.00M | -- | -- |
| Cash from Financing | 611.00M | 606.00M | 593.00M | 9.00M | 21.00M |
| Foreign Exchange rate Adjustments | 0.00 | 3.00M | 2.00M | 1.00M | 1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 443.00M | 283.00M | 668.00M | -513.00M | -1.20B |